Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nyberg

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
CPT: Pharmacometrics & Systems Pharmacology|August 23, 2024
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end pointsXiaomei Chen, Henrik B Nyberg, Mark Donnelly, et al.
The American Journal of Physiology|April 13, 1999
Depression of liver protein synthesis during surgery is prevented by growth hormoneH Barle, P Essén, B Nyberg, et al.
Neurogastroenterology and Motility|March 12, 2008
Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospyC H Knowles, B Veress, H Tornblom, et al.
The Journal of Clinical Endocrinology and Metabolism|February 18, 1999
Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humansH Olivecrona, A Hilding, C Ekström, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
Model Description Language (MDL): A Standard for Modeling and SimulationMike K Smith, Stuart L Moodie, Roberto Bizzotto, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug DevelopmentM J Swat, S Moodie, S M Wimalaratne, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
CPT: Pharmacometrics & Systems Pharmacology|August 23, 2024
Development and comparison of model-integrated evidence approaches for bioequivalence studies with pharmacokinetic end pointsXiaomei Chen, Henrik B Nyberg, Mark Donnelly, et al.
The American Journal of Physiology|April 13, 1999
Depression of liver protein synthesis during surgery is prevented by growth hormoneH Barle, P Essén, B Nyberg, et al.
Neurogastroenterology and Motility|March 12, 2008
Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospyC H Knowles, B Veress, H Tornblom, et al.
The Journal of Clinical Endocrinology and Metabolism|February 18, 1999
Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humansH Olivecrona, A Hilding, C Ekström, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
Model Description Language (MDL): A Standard for Modeling and SimulationMike K Smith, Stuart L Moodie, Roberto Bizzotto, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2015
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug DevelopmentM J Swat, S Moodie, S M Wimalaratne, et al.
Pageof 6